Synex Medical Analysis: $35M Raised
What is Synex Medical?
Synex Medical develops non-invasive health monitoring technology using magnetic resonance spectroscopy to measure blood metabolites like glucose and lactate. Their compact, portable devices aim to enable predictive and personalized medicine by providing real-time metabolic data without the discomfort of needles. Founded by Ben Nashman, the company has grown to a team of 30 professionals focused on advancing health monitoring solutions.
Location
123 Front Street West, Toronto, Ontario, Canada
Employees
51-200
Founded
2017
Funding Status
Series A
Product Features & Capabilities
- Portable magnetic resonance spectroscopy devices
- Real-time glucose and lactate measurement
- Non-invasive health monitoring technology
Use Cases
Measure glucose levels without needles; Monitor lactate concentrations in athletes; Provide real-time metabolic data for diabetes management; Enable predictive health assessments in clinical settings; Support personalized medicine through continuous health monitoring
Other Considerations
Raised Series A funding; Supported by experts from Harvard and University of Toronto; Team includes PhDs from top institutions; Early prototype developed at Mount Sinai; Recognized for groundbreaking portable MRI technology
See something that needs updating? Suggest edits to this profile.